Actelion’s Opsumit improves pulmonary vascular resistance in trial of portopulmonary hypertension

Image: Actelion’s Opsumit has improved pulmonary vascular resistance in trial of portopulmonary hypertension. Photo: courtesy of Jan Friml / FreeImages.